Abstract
The findings from this study indicate that a heat pain test may determine whether opioids should or should not be the first drugs used for patients with postherpetic neuralgia. The results may help to stratify patients with postherpetic neuralgia for the best treatment choice. The authors analyzed data from 64 patients who had participated in a randomized, double-blind, placebo-controlled, crossover trial for the treatment of postherpetic neuralgia. Heat pain thresholds on the unaffected side of patients with postherpetic neuralgia correlated with pain relief after opioid treatment. Higher baseline heat pain thresholds predicted larger reductions in pain and higher pain relief ratings. Further, higher initial pain intensity was associated with a larger percentage reduction in pain. Older age predicted less of a reduction in pain intensity and less pain relief after treatment with opioids.